4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic DermatitisSkin Diseases, Eczematous, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, dermatitis, sebaceous gland disorder, seborrheic dermatitis, skin disorderNot yet recruitingPhase 32026-08-21NCT07683806
China HeadAche DIsorders RegiStryAnalgesic Overuse Headache, Headache Disorders, Secondary, Tension-Type Headache, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder, trigeminal autonomic cephalalgiaRecruitingNot stated2026-07-10NCT05334927
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous UrticariaChronic Disease, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticariaRecruitingPhase 2 / Phase 32026-04-21NCT07378527
ICP-332 in Subjects With Non-segmental VitiligoNon Segmental VitiligoRecruitingPhase 2 / Phase 32025-08-07NCT07047612